Article Text

Download PDFPDF

Correction: 2021 DORIS definition of remission in SLE: final recommendations from an international task force

Statistics from Altmetric.com

van Vollenhoven RF, Bertsias G, Doria A, et al. 2021 DORIS definition of remission in SLE: final recommendations from an international task force. Lupus Sci Med 2021;8:e000538. doi: 10.1136/lupus-2021-000538

The authors want to alert the readers that a typographical error noticed in Box 1, has now been corrected. The final bullet point, referring to medications, was corrected from (prednisolone <5 mg/day) to (prednisolone <5 mg/day), as shown below.

Box 1

The 2021 DORIS definition of remission in SLE

  • Clinical SLEDAI=0.

  • Physician Global Assessment <0.5 (0–3).

    • Irrespective of serology.

    • The patient may be on antimalarials, low-dose glucocorticoids (prednisolone ≤5 mg/day), and/or stable immunosuppressives including biologics.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.